An integrative ENCODE resource for cancer genomics
Jing ZhangiD, Donghoon LeeiD, Vineet K. DhimaniD, Peng JiangiD, Jie XuiD, Patrick D. McGillivrayiD, Hongbo YangiD, Jason J. LiuiD, William U. MeyersoniD, Declan ClarkeiD, Mengting GuiD, Shantao LiiD, Shaoke LouiD, Jinrui XuiD, Lucas LochovskyiD, Matthew H. UngiD, Lijia MaiD, Shan YuiD, Qin CaoiD, Arif O. HarmanciiD, Koon-Kiu Yan, Anurag SethiiD, Gamze GürsoyiD, Michael Rutenberg Schoenberg, Joel S. RozowskyiD, , Mark GersteiniD
Abstract
ENCODE comprises thousands of functional genomics datasets, and the encyclopedia covers hundreds of cell types, providing a universal annotation for genome interpretation. However, for particular applications, it may be advantageous to use a customized annotation. Here, we develop such a custom annotation by leveraging advanced assays, such as eCLIP, Hi-C, and whole-genome STARR-seq on a number of data-rich ENCODE cell types. A key aspect of this annotation is comprehensive and experimentally derived networks of both transcription factors and RNA-binding proteins (TFs and RBPs). Cancer, a disease of system-wide dysregulation, is an ideal application for such a network-based annotation. Specifically, for cancer-associated cell types, we put regulators into hierarchies and measure their network change (rewiring) during oncogenesis. We also extensively survey TF-RBP crosstalk, highlighting how SUB1, a previously uncharacterized RBP, drives aberrant tumor expression and amplifies the effect of MYC, a well-known oncogenic TF. Furthermore, we show how our annotation allows us to place oncogenic transformations in the context of a broad cell space; here, many normal-to-tumor transitions move towards a stem-like state, while oncogene knockdowns show an opposing trend. Finally, we organize the resource into a coherent workflow to prioritize key elements and variants, in addition to regulators. We showcase the application of this prioritization to somatic burdening, cancer differential expression and GWAS. Targeted validations of the prioritized regulators, elements and variants using siRNA knockdowns, CRISPR-based editing, and luciferase assays demonstrate the value of the ENCODE resource.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 172
- FWCI
- 7.46
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chromatin Landscape of Cancer Cell Lines Identifies Enhancer Subtypes
Mayinuer Maitituoheti, Emre Arslan, … Kunal Rai·bioRxiv·Aug 4, 2026
- Regulation Network of Colorectal Cancer Specific Enhancers in Progression of Colorectal Cancer
Bohan Chen, MA Yi-ping, … Lei Zhang·International Journal of Molecular SciencesPeer-reviewed·Aug 3, 2021
- Pan-cancer analysis of RNA binding proteins (RBPs) reveals the involvement of the core pre-mRNA splicing and translation machinery in tumorigenesis
Bin Zhang, Kamesh R. Babu, … Yvonne Tay·bioRxiv·Jun 7, 2018
- BART Cancer: a web resource for transcriptional regulators in cancer genomes
Z. V. Thomas, Z. Wang, C. Zang·bioRxiv·Dec 17, 2020
- Enhancer regulatory networks globally connect non-coding breast cancer loci to cancer genes
Yihan Wang, Daniel A. Armendariz, … Gary C. Hon·Genome biologyPeer-reviewed·Jan 17, 2025
- A large-scale cancer-specific protein-DNA interaction network
Yunwei Lu, Anna Berenson, … Juan I. Fuxman Bass·Life Science AlliancePeer-reviewed·Jul 16, 2024